Monday - February 17, 2020
Rep. Walker Encourages FDA to Expand Patient Access to Potentially Lifesaving Drugs
July 11, 2019
WASHINGTON, July 11 -- Rep. Mark Walker, R-North Carolina, issued the following news releae:

U.S. Representative Mark Walker (R-N.C.) recently led a letter to Dr. Norman E. Sharpless, the acting Commissioner of the U.S. Food and Drug Administration (FDA), encouraging the FDA to expand the Parallel Track and improve patient access to potentially lifesaving medications that have been deemed safe, but not fully approved by the agency.

The letter is signed by U.S. Represent . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products